09:42 AM EST, 11/27/2024 (MT Newswires) -- AIM ImmunoTech ( AIM ) said Wednesday its independent directors will now get 100% of their board compensation in the company's common shares instead of any director compensation in cash under a cash conservation plan devised by the compensation committee.

The company intends to attain important clinical benchmarks under the cash conservation plan, it added.

AIM said it will continue to disclose additional details about the conservation plan.

Shares of the company were down 1.8% in recent Wednesday trading.